Implementing best available evidence into practice for incontinence-associated dermatitis in Australia: A multisite multimethod study protocol. Issue 1 (February 2021)

• Record Type: Journal Article
• Authors: Barakat-Johnson, Michelle; Basjarahil, Shifa; Campbell, Jayne; Cunich, Michelle; Disher, Gary; Geering, Samara; Ko, Natalie; Lai, Michelle; Leahy, Catherine; Leong, Thomas; McClure, Eve; O'Grady, Melissa; Walsh, Joan; White, Kate; Coyer, Fiona
• Is Part Of: Journal of tissue viability. Volume 30:Issue 1(2021)
• Page Start: 67
• Page End: 77
• Publication Date: 2021-02
• Subjects: GLOBIAD tool -- Guidelines -- Implementation science -- Incontinence-associated dermatitis -- Pressure injury; Wounds and injuries -- Periodicals; Ulcers -- Periodicals; Bedsores -- Periodicals; Bedsores; Ulcers; Wounds and injuries; Electronic journals; Periodicals; 617.1406
• DOI: 10.1016/j.jtv.2020.10.002
• Languages: English
• ISSNs: 0965-206X

Abstract

Abstract: Aims: Incontinence-associated dermatitis (IAD) is an insidious and under-reported hospital-acquired complication which substantially impacts on patients' quality of life. A published international guideline and the Ghent Global IAD Categorisation Tool (GLOBIAD) outline the best available evidence for the optimal management of IAD. This study aims to implement theguideline and the GLOBIAD tool and evaluate the effect on IAD occurrences and sacral pressure injuries as well as patient, clinician and cost-effectiveness outcomes. Materials and methods: The study will employ a multi-method design across six hospitals in five health districts in Australia, and will be conducted in three phases (pre-implementation, implementation and post-implementation) over 19 months. Data collection will involve IAD and pressure injury prevalence audits for patient hospital admissions, focus groups with, and surveys of, clinicians, patient interviews, and collection of the cost of IAD hospital care and patient-related outcomes including quality of life. Eligible participants will be hospitalised adults over 18 years of age experiencing incontinence, and clinicians working in the study wards will be invited to participate in focus groups and surveys. Conclusion: The implementation of health district-wide evidence-based practices for IAD using a translational research approach that engages key stakeholders will allow the standardisation of IAD care that can potentially be applicable to a range of settings. Knowledge gained will inform future practice change in patient care and health service delivery and improve the quality of care for patients with IAD. Support at the hospital, state and national levels, coupled with a refined stakeholder-inclusive strategy, will enhance this project's success, sustainability and scalability beyond this existing project. Highlights: Incontinence-associated dermatitis (IAD) is a common, underreported skin condition. This study will implement both IAD best practice guidelines and the GLOBIAD tool. No study, to date, has implemented the guidelines and tool as a bundled approach. This study aims to translate evidence into practice to prevent and manage IAD. This study will be carried out in six acute care hospitals in one Australian state.